New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers and some providers, faced considerable downward pressure. This divergence highlights a sector grappling with a flurry of groundbreaking drug
As of November 10, 2025, a palpable wave of optimism is sweeping through global financial markets, fueled by significant progress in the US Senate towards ending the longest government shutdown in American history, now in its 41st day. The advancement of a bipartisan bill aimed at resolving the impasse has
New York, NY – November 10, 2025 – The Dow Jones Industrial Average surged today, fueled by a wave of investor optimism surrounding a potential breakthrough deal to end the protracted U.S. government shutdown. After weeks of uncertainty and market apprehension, the prospect of a legislative resolution has injected a much-needed
Washington D.C. – November 10, 2025 – The United States federal government finds itself in an unprecedented fiscal quagmire, entering its 41st day of the longest shutdown in the nation's history. The impasse, which began on October 1, 2025, after a failure to pass appropriations legislation for the 2026 fiscal year,
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to December and raising premium concerns.
In a surprising turn of events on November 10, 2025, UnitedHealth Group (NYSE: UNH), a titan in the healthcare industry, saw its stock tumble significantly, shedding several percentage points of its market capitalization. This downturn sharply contrasted with a generally buoyant market, where major indices like the S&P 500
November 6, 2025 – Humana Inc. (NYSE: HUM) shares experienced a significant downturn today, mirroring a broader negative trend across the market. While specific real-time triggers for this hypothetical date are beyond current predictive capabilities, the scenario points to a confluence of factors that could typically impact a major health insurer,
Shares of health insurance company Humana (NYSE:HUM)
fell 8.4% in the morning session after the company's third-quarter earnings report revealed a significant miss on profit estimates, fueling concerns about declining profitability. While the company reported revenue of $32.65 billion, beating analysts' expectations, its GAAP earnings per share (EPS) of $1.62 came in 43.4% below the consensus estimate of $2.86. The pressure on profitability was evident as Humana's operating margin fell to 1.2%, down from 2.5% in the same quarter last year. Adding to investor worries, the company's customer base also fell slightly short of Wall Street’s forecasts. Overall, despite Humana reaffirming its full-year revenue guidance, the sharp earnings miss and shrinking margins led to a negative market reaction.
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing another interest rate cut.
Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Health insurance company Humana (NYSE:HUM) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 11.4% year on year to $32.65 billion. The company expects the full year’s revenue to be around $128 billion, close to analysts’ estimates. Its GAAP profit of $1.62 per share was 43.4% below analysts’ consensus estimates.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Humana beat Q3 2025 earnings estimates with adjusted EPS of $3.24. Despite the profit beat, shares fell due to a significant gap between GAAP and non-GAAP results and revised full-year guidance.
